|
"徐志宏"的相关文件
显示项目 21-70 / 154 (共4页)
1 2 3 4 > >>
每页显示[10|25|50]项目
| 國立臺灣大學 |
2016 |
Serum biomarkers of VEGF-A and TGF-beta 1 predict pathological response and survival of esophageal cancer patients treated with neoadjuvant chemoradiotherapy and esophagectomy
|
Cheng, Jason Chia-Hsien; Chiang, Yun; Hsu, Feng-Ming; Tsai, Chiao-Ling; Hsu, Chih-Hung; Lee, Jang-Ming; 成佳憲; 徐志宏; 李章銘; 蔡巧琳; 許?銘 |
| 國立臺灣大學 |
2015 |
Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer
|
Yeh, Chao-Chi; Hsu, Chih-Hung; Shao, Yu-Yun; Ho, Wen-Ching; Tsai, Mong-Hsun; Feng, Wen-Chi; Chow, Lu-Ping; 邵幼雲; 周綠蘋; 徐志宏 |
| 國立臺灣大學 |
2015 |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Wang, Chia-Chun; Cheng, Jason Chia-Hsien; Tsai, Chiao-Ling; Lee, Jang-Ming; Huang, Pei-Ming; Lin, Chia-Chi; Hsu, Chih-Hung; Hsieh, Min-Shu; Chang, Yih-Leong; Hsu, Feng-Ming; 林家齊; 張逸良; 成佳憲; 王嘉檇; 徐志宏; 謝明書; 李章銘; 黃培銘; 蔡巧琳; 許峰銘 |
| 國立臺灣大學 |
2015 |
Postchemoradiotherapy (CRT) pathologic stage classified by American Joint Committee on Cancer (AJCC) staging system to predict prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC)
|
Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 林家齊; 鄭安理; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 王秀伯; 張晉豪 |
| 國立臺灣大學 |
2015 |
Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
|
Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Huang, Pei-Ming; Lee, Jang-Ming; Hsu, Feng-Ming; Cheng, Jason Chia-Hsien; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 林家齊; 鄭安理; 成佳憲; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 李章銘; 王秀伯; 黃培銘; 許峰銘; 張晉豪 |
| 國立臺灣大學 |
2015 |
Therapeutic effect of sorafenib is attenuated by tumor-infiltrating Ly6G+myeloid-derived suppressor cells (MDSCs) and is restored by anti-interleukin-6 (IL-6) antibody treatment in an orthotopic mouse liver cancer model
|
Chang, Chun-Jung; Yang, Yao-Hsu; Chiu, Chiao-Juno; Chiang, Bor-Luen; Lee, Xiao-yi; Hsu, Chih-Hung; Cheng, Ann-Lii; 張純榮; 鄭安理; 徐志宏; 江伯倫; 楊曜旭 |
| 國立臺灣大學 |
2015 |
Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials
|
Shao, Yu-Yun; Shau, Wen-Yi; Chan, Soa-Yu; Lu, Li-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2015 |
Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan
|
Shao, Yu-Yun; Hsu, Chih-Hung; Yeh, Kun-Huei; Chen, Ho-Min; Yeh, Yi-Chun; Lai, Chiu-Lin; Lin, Zhong-Zhe; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 葉坤輝 |
| 國立臺灣大學 |
2015 |
Tumor c-Met expression and prognosis of advanced hepatocellular carcinoma patients treated with sorafenib
|
Shao, Yu Yun; Hsiao, Chi-Huang; Lee, Ray; Puig, Oscar; Chan, Soa-Yu; Li, Yong-Shi; Hsu, Chih-Hung; 徐志宏 |
| 國立臺灣大學 |
2015 |
High Serum Transforming Growth Factor-beta 1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib
|
Lin, Tzu-Hsuan; Shao, Yu-Yun; Chan, Soa-Yu; Huang, Chung-Yi; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 黃昭源; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2015 |
Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer
|
Huang, Ta-Chen; Hsu, Chih-Hung; Lin, Chia-Chi; Tu, Yu-Kang; 林家齊; 杜裕康; 黃大成; 徐志宏 |
| 國立臺灣大學 |
2015 |
Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?
|
Shao, Yu-Yun; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2015 |
Serum Transforming Growth Factor-beta 1 Change After Neoadjuvant Chemoradiation Therapy Is Associated With Postoperative Pulmonary Complications in Esophageal Cancer Patients Undergoing Combined Modality Therapy
|
Lu, Shao-Lun; Hsu, Feng-Ming; Tsai, Chiao-Ling; Wu, Jian-Kuan; Lee, Jang-Ming; Huang, Pei-Ming; Hsu, Chih-Hung; Koong, Albert C.; Chang, Daniel T.; Cheng, Jason Chia-Hsien; 成佳憲; 徐志宏; 李章銘; 黃培銘; 蔡巧琳; 許峰銘; 吳簡坤 |
| 國立臺灣大學 |
2014 |
beta-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma
|
Lu, Li-Chun; Shao, Yu-Yun; Lee, Yi-Hsuan; Hsieh, Min-Shu; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; 高祥豐; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書; 李宜軒 |
| 國立臺灣大學 |
2014 |
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin, C-C; Su, W-C; Yen, C-J; Hsu, C-H; Su, W-P; Yeh, K-H; Lu, Y-S; Cheng, A-L; Huang, D. C-L; Fritsch, H.; Voss, F.; Taube, T.; Yang, J. C-H; 林家齊; 楊志新; 盧彥伸; 鄭安理; 徐志宏; 葉坤輝 |
| 國立臺灣大學 |
2014 |
Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases
|
Shao, Yu-Yun; Ho, Ming-Chih; Cheng, Ann-Lii; Hsu, Chih-Hung; 邵幼雲; 鄭安理; 徐志宏; 何明志 |
| 國立臺灣大學 |
2014 |
Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy
|
Shao, Yu-Yun; Wu, Chih-Horng; Lu, Li-Chun; Chan, Soa-Yu; Ma, Yu-Yi; Yen, Feng-Chu; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 吳志宏; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2014 |
Clinical Characteristics of Advanced Hepatocellular Carcinoma Patients with Prolonged Survival in the Era of Anti-angiogenic Targeted-therapy
|
Lu, Li-Chun; Shao, Yu-Yun; Chan, Soa-Yu; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2014 |
Increased sensitivity to Wnt/beta-catenin inhibitors in hepatocellular carcinoma cells harboring activating mutation of beta-catenin
|
Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Hsu, Ta-Wen; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2014 |
High serum transforming growth factor beta 1 levels associated with poor survivals in patients with advanced hepatocellular carcinoma
|
Lin, Tzu-Hsuan; Shao, Yu-Yun; Chan, Soa-Yu; Huang, Chung-Yi; Cheng, Ann-Lii; Hsu, Chih-Hung; 邵幼雲; 黃昭源; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2013 |
Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma
|
Lu, Li-Chun; Shao, Yu-Yun; Kuo, Raymond N. C.; Lin, Zhong-Zhe; Yeh, Yi-Chun; Shau, Wen-Yi; Hsu, Chih-Hung; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 郭年真; 呂理駿 |
| 國立臺灣大學 |
2013 |
Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study
|
Hsu, Chih-Hung; Kang, Yoon Koo; Yang, Tsai-Shen; Shun, Chia-Tung; Shao, Yu-Yun; Su, Wu-Chou; Sandoval-Tan, Jennifer; Chiou, Tzeon-Jye; Jin, Kate; Hsu, Chiun; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 許駿; 孫家棟 |
| 國立臺灣大學 |
2013 |
Nuclear Expression of Glioma-Associated Oncogene Homo log 1 and Nuclear Factor-kappa B Is Associated with a Poor Prognosis of Pancreatic Cancer
|
Yang, Shih-Hung; Hsu, Chih-Hung; Lee, Jen-Chieh; Tien, Yu-Wen; Kuo, Sung-Hsin; Cheng, Ann-Lii; 郭頌鑫; 鄭安理; 李仁傑; 徐志宏; 田郁文; 楊士弘 |
| 國立臺灣大學 |
2013 |
Prognostic Factors of Metastatic or Recurrent Esophageal Squamous Cell Carcinoma in Patients Receiving Three-drug Combination Chemotherapy
|
Chen, Wei-Wu; Lin, Chia-Chi; Huang, Ta-Chen; Cheng, Ann-Lii; Yeh, Kun-Huei; Hsu, Chih-Hung; 林家齊; 陳偉武; 鄭安理; 黃大成; 徐志宏; 葉坤輝 |
| 國立臺灣大學 |
2013 |
The Germline BIM Deletion Polymorphism Is Not Associated with the Treatment Efficacy of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
|
Shao, Yu-Yun; Chang, Yung-Lin; Huang, Chung-Yi; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 黃昭源; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2013 |
Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size
|
Lin, Zhong-Zhe; Shau, Wen-Yi; Hsu, Chiun; Shao, Yu-Yun; Yeh, Yi-Chun; Kuo, Raymond Nien-Chen; Hsu, Chih-Hung; Yang, James Chih-Hsin; Cheng, Ann-Lii; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2013 |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
Shao, Yu-Yun; Liang, Po-Chin; Wu, Yao-Ming; Huang, Chun-Chieh; Huang, Kai-Wen; Cheng, Jason C.; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; Lin, Zhong-Zhe; 邵幼雲; 林宗哲; 鄭安理; 成佳憲; 黃凱文; 徐志宏; 許駿; 梁博欽; 吳耀銘 |
| 國立臺灣大學 |
2013 |
Survival of patients receiving radiofrequency ablation or ethanol injection for early-stage hepatocellular carcinoma.
|
Lin, Zhong-Zhe; Shau, Wen-Yi; Shao, Yu Yun; Yeh, Yi-Chun; Kuo, Raymond Nien-Chen; Hsu, Chiun; Hsu, Chih-Hung; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿; 郭年真 |
| 國立臺灣大學 |
2013 |
WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells.
|
Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung; 邵幼雲; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2013 |
Unique histopathologic features of brain metastases from hepatocellular carcinoma
|
Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Lu, Li-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書 |
| 國立臺灣大學 |
2013 |
Prevalence of gene amplifications of SOX-2, c-MET, and FGFR1 in Asian patients with esophageal squamous cell carcinoma.
|
Huang, Ta-Chen; Chen, Wei-Wu; Hsu, Ta-Wen; Lin, Chia-Chi J.; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 林家齊; 鄭安理; 黃大成; 徐志宏; 葉坤輝 |
| 國立臺灣大學 |
2013 |
Vascular endothelial growth factor expression in hepatitis C virus (HCV)-related advanced hepatocellular carcinoma (HCC) compared with hepatitis B virus (HBV)-related advanced HCC
|
Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Chang, Yung-Ling; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 謝明書 |
| 國立臺灣大學 |
2012 |
Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma
|
Yen, T. -J.; Chung, C. -S.; Wu, Y. -W.; Yen, R. -F.; Cheng, M. -F.; Lee, J. -M.; Hsu, C. -H.; Chang, Y. -L.; Wang, H. -P.; 吳彥雯; 張逸良; 顏若芳; 徐志宏; 李章銘; 王秀伯; 鄭媚方 |
| 國立臺灣大學 |
2012 |
Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma
|
Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chiun; Lee, Kuan-Der; Hsiao, Chi-Huang; Lu, Yen-Shen; Huang, Chien-Chung; Shen, Yin-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 盧彥伸; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2012 |
Factors Impacting Prognosis Prediction in BCLC Stage C and Child-Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy
|
Lin, Zhong-Zhe; Hsu, Chiun; Hu, Fu-Chang; Shao, Yu-Yun; Chang, Dwan-Ying; Yang, Chih-Hsin; Hong, Ruey-Long; Hsu, Chih-Hung; Cheng, Ann-Lii; 楊志新; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 洪瑞隆; 許駿; 胡賦強; 張端瑩 |
| 國立臺灣大學 |
2012 |
Serum Insulin-Like Growth Factor-1 Levels Predict Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy
|
Shao, Yu-Yun; Huang, Chien-Chung; Lin, Shiou-Der; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2012 |
Metastasectomy of Krukenberg Tumors May Be Associated with Survival Benefits in Patients with Metastatic Gastric Cancer
|
Lu, Li-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Hsu, Chun; Cheng, Wen-Fang; Lin, Yu-Lin; Cheng, Ann-Lii; Yeh, Kun-Huei; 鄭文芳; 邵幼雲; 林育麟; 鄭安理; 徐志宏; 許駿; 葉坤輝; 呂理駿 |
| 國立臺灣大學 |
2012 |
FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR EVALUATING EARLY RESPONSE DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
|
Lin, C. -C.; Hsu, C. -H.; Tzen, K. -Y.; Cheng, J. C.; Lee, J. -M.; Wang, H. -P.; Huang, P. -M.; Hsu, F. -M.; Chen, W. -W.; Huang, T. -C.; Cheng, A. -L.; 林家齊; 曾凱元; 鄭安理; 成佳憲; 黃大成; 徐志宏; 李章銘; 王秀伯; 黃培銘; 許峰銘 |
| 國立臺灣大學 |
2012 |
HOSPITAL VOLUMES OF PERCUTANEOUS RADIOFREQUENCY ABLATION ASSOCIATED WITH ITS TREATMENT OUTCOMES FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA
|
Shao, Y. -Y.; Lu, L. -C.; Kuo, R. N. C.; Lin, Z. -Z.; Yeh, Y. -C.; Shau, W. -Y.; Hsu, C. -H.; Cheng, A. -L.; Lai, M. -S.; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2012 |
SYNERGISTIC ANTI-TUMOR EFFECT OF SORAFENIB IN COMBINATION WITH AKT INHIBITORS IN HEPATOCELLULAR CARCINOMA
|
Feng, W. -C.; Hsu, C. -H.; Lin, S. -D.; Lin, H. -H.; Hsu, D. -W.; Huang, C. -C.; Chow, L. -P.; Cheng, A. -L.; 周綠蘋; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2012 |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao, Y-Y; Lu, L-C; Lin, Z-Z; Hsu, C.; Shen, Y-C; Hsu, C-H; Cheng, A-L; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿; 呂理駿 |
| 國立臺灣大學 |
2012 |
THE ROLES OF GROWTH ARREST DNA DAMAGE-INDUCIBLE GENE 45 Gamma (GADD45 Gamma) EXPRESSION IN SORAFENIB-INDUCED APOPTOSIS IN HEPATOCELLULAR CARCINOMA (HCC) CELLS
|
Hsu, C.; Ou, D. -L.; Shiau, C. -W.; Fan, H. -H.; Liao, S. -C.; Lin, Y. -Y.; Hsu, C. -H.; Cheng, A. -L.; 林育誼; 鄭安理; 徐志宏; 許駿; 歐大諒 |
| 國立臺灣大學 |
2012 |
Dissimilar Immunohistochemical Expression of ERK and AKT between Paired Biopsy and Hepatectomy Tissues of Hepatocellular Carcinoma
|
Shao, Yu-Yun; Chen, Chi-Long; Ho, Ming-Chih; Huang, Chien-Chung; Tu, Hui-Ching; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 何明志 |
| 國立臺灣大學 |
2012 |
Diabetes Mellitus Is Associated with Increased Mortality in Patients Receiving Curative Therapy for Hepatocellular Carcinoma
|
Shau, Wen-Yi; Shao, Yu-Yun; Yeh, Yi-Chun; Lin, Zhong-Zhe; Kuo, Raymond; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2012 |
Brivanib (BRI) versus Sorafenib (SOR) as First-line Therapy in Patients with Unresectable, Advanced Hepatocellular Carcinoma (HCC): Results from the Phase 3 BRISK-FL Study
|
Johnson, Phillip; Qin, Shukui; Park, Joong-Won; Poon, Ronnie T.; Raoul, Jean-Luc; Philip, Philip A.; Hsu, Chih-Hung; Hu, Tsung-Hui; Heo, Jeong; Xu, Jianming; Lu, Ligong; Chao, Yee; Boucher, Eveline; Han, Kwang-Hyub; Paik, Seung Woon; Robles-Avina, Jorge; Kudo, Masatoshi; Liu, David; Ezzeddine, Rana; Walters, Ian; Cheng, Ann-Lii; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2012 |
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Tzen, Kai-Yuan; Cheng, Jason C.; Lee, Jang-Ming; Wang, Hsiu-Po; Huang, Pei-Ming; Hsu, Feng-Ming; Chen, Wei-Wu; Huang, Ta-Chen; Cheng, Ann-Lii; 林家齊; 曾凱元; 鄭安理; 成佳憲; 黃大成; 徐志宏; 李章銘; 王秀伯; 黃培銘; 許峰銘 |
| 國立臺灣大學 |
2012 |
LOW FREQUENCIES OF BRAF AND B-CATENIN (CTNNB1) MUTATIONS IN ADVANCED HEPATOCELLULAR CARCINOMA
|
Lu, L. -C.; Shao, Y. -Y.; Hsieh, M. -S.; Huang, C. -C.; Cheng, A. -L.; Hsu, C. -H.; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書 |
| 臺大學術典藏 |
2012 |
Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma
|
Yen, T. -J.;Chung, C. -S.;Wu, Y. -W.;Yen, R. -F.;Cheng, M. -F.;Lee, J. -M.;Hsu, C. -H.;Chang, Y. -L.;Wang, H. -P.; 吳彥雯 ;張逸良 ;顏若芳 ;徐志宏 ;李章銘 ;王秀伯 ;鄭媚方; 吳彥雯 ;張逸良 ;顏若芳 ;徐志宏 ;李章銘 ;王秀伯 ;鄭媚方; Yen, T. -J.; Yen, T. -J.; Chung, C. -S.; Chung, C. -S.; Wu, Y. -W.; Yen, R. -F.; Yen, R. -F.; Cheng, M. -F.; Lee, J. -M.; Hsu, C. -H.; Chang, Y. -L.; Wang, H. -P.; 張逸良; 張逸良 |
| 國立臺灣海洋大學 |
2011-06 |
建構綠色供應鏈供應商採購之績效評比模式
|
徐志宏;梁金樹 |
| 國立臺灣海洋大學 |
2011 |
流通服務業發展綠色供應鏈動態績效評價系統之研究－從國際物流觀點
|
Chih-Hung Hsu; 徐志宏 |
显示项目 21-70 / 154 (共4页)
1 2 3 4 > >>
每页显示[10|25|50]项目
|
